Exercise in systemic sclerosis intensifies systemic inflammation and oxidative stress

References

• Tamby MC, Chanseaud Y, Guillevin L, Mouthon L. New insights into the pathogenesis of systemic sclerosis. Autoimmun Rev 2003; 2: 152–7
   PubMed Web of Science ®Google Scholar
• Derk CT, Jimenez SA. Systemic sclerosis: current views of its pathogenesis. Autoimmun Rev 2003; 2: 181–91
   PubMed Web of Science ®Google Scholar
• Kampolis C, Plastrias S, Vlachoyiannopoulos P, Moyssakis I, Tzelepis G. The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis. Scand J Rheumatol 2008; 37: 278–83
   PubMed Web of Science ®Google Scholar
• Murrell DF. A radical proposal for the pathogenesis of scleroderma. J Am Acad Dermatol 1993; 28: 78–85
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. Oxford University Press, Oxford 1999
   Google Scholar
• Roumm AD, Whiteside TL, Medsger TA, Jr, Rodnan GP. Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. Arthritis Rheum 1984; 27: 645–53
   PubMed Web of Science ®Google Scholar
• Lloyd CM, Minto AW, Dorf ME, Proudfoot A, Wells TN, Salant DJ, et al. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 1997; 185: 1371–80
   PubMed Web of Science ®Google Scholar
• Chesney J, Bucala R. Peripheral blood fibrocytes: mesenchymal precursor cells and the pathogenesis of fibrosis. Curr Rheumatol Rep 2000; 2: 501–5
   PubMedGoogle Scholar
• Distler O, Rinkes B, Hohenleutner U, Scholmerich J, Landthaler M, Lang B, et al. Expression of RANTES in biopsies of skin and upper gastrointestinal tract from patients with systemic sclerosis. Rheumatol Int 1999; 19: 39–46
   PubMed Web of Science ®Google Scholar
• Leroy EC, Smith EA, Kahaleh MB, Trojanowska M, Silver RM. A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer?. Arthritis Rheum 1989; 32: 817–25
   PubMed Web of Science ®Google Scholar
• Majewski S, Wojas-Pelc A, Malejczyk M, Szymanska E, Jablonska S. Serum levels of soluble TNF alpha receptor type I and the severity of systemic sclerosis. Acta Derm Venereol 1999; 79: 207–10
   PubMed Web of Science ®Google Scholar
• Hasegawa M, Fujimoto M, Kikuchi K, Takehara K. Elevated serum tumor necrosis factor-alpha levels in patients with systemic sclerosis: association with pulmonary fibrosis. J Rheumatol 1997; 24: 663–5
   PubMed Web of Science ®Google Scholar
• Scala E, Pallotta S, Frezzolini A, Abeni D, Barbieri C, Sampogna F, et al. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol 2004; 138: 540–6
   PubMed Web of Science ®Google Scholar
• Sato S, Hasegawa M, Takehara K. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. J Dermatol Sci 2001; 27: 140–6
   PubMed Web of Science ®Google Scholar
• Schwaiblmair M, Behr J, Fruhmann G. Cardiorespiratory responses to incremental exercise in patients with systemic sclerosis. Chest 1996; 110: 1520–5
   PubMed Web of Science ®Google Scholar
• Van Helvoort HA, van de Pol MH, Heijdra YF, Dekhuijzen PN. Systemic inflammatory response to exhaustive exercise in patients with chronic obstructive pulmonary disease. Respir Med 2005; 99: 1555–67
   PubMed Web of Science ®Google Scholar
• Valentini S, D'Angelo S, Della Rossa A, Bencivelli W, Bombardieri S. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score. Ann Rheum Dis 2003; 62: 904–5
   PubMed Web of Science ®Google Scholar
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980, 23: 581–90.
   PubMed Web of Science ®Google Scholar
• ATS/ACCP. Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003, 167:211–77.
   PubMed Web of Science ®Google Scholar
• Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986; 60: 2020–7
   PubMed Web of Science ®Google Scholar
• Conti M, Morand PC, Levillain P, Lemonnier A. Improved fluorometric determination of malonaldehyde. Clin Chem 1991; 37: 1273–5
   PubMed Web of Science ®Google Scholar
• Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn CC. Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med 1997; 23: 361–6
   PubMed Web of Science ®Google Scholar
• Zusterzeel PL, Mulder TP, Peters WH, Wiseman SA, Steegers EA. Plasma protein carbonyls in nonpregnant, healthy pregnant and preeclamptic women. Free Radic Res 2000; 33: 471–6
   PubMed Web of Science ®Google Scholar
• Wanten GJ, Naber AH, Kruimel JW, Tool AT, Roos D, Jansen JB. Influence of structurally different lipid emulsions on human neutrophil oxygen radical production. Eur J Clin Invest 1999; 29: 357–63
   PubMed Web of Science ®Google Scholar
• Dill DB, Costill DL. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol 1974; 37: 247–8
   PubMed Web of Science ®Google Scholar
• Leroy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202–5
   PubMed Web of Science ®Google Scholar
• Sudduth CD, Strange C, Cook WR, Miller KS, Baumann M, Collop NA, et al. Failure of the circulatory system limits exercise performance in patients with systemic sclerosis. Am J Med 1993; 95: 413–18
   PubMed Web of Science ®Google Scholar
• Wasserman K, Hansen JE, Sue DY, Whipp BJ, Casaburi R. Principles of exercise testing and interpretation4th edn. Lippincott Williams & Wilkins, Baltimore 2005
   Google Scholar
• Alkotob ML, Soltani P, Sheatt MA, Katsetos MC, Rothfield N, Hager WD, et al. Reduced exercise capacity and stress-induced pulmonary hypertension in patients with scleroderma. Chest 2006; 130: 176–181
   PubMed Web of Science ®Google Scholar
• Steen V, Medsger TA, Jr. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003; 48: 516–22
   PubMed Web of Science ®Google Scholar
• de Oliveira NC, dos Santos Sabbag LM, Ueno LM, de Souza RB, Borges CL, de Sa Pinto AL, et al. Reduced exercise capacity in systemic sclerosis patients without pulmonary involvement. Scand J Rheumatol 2007; 36: 458–61
   PubMed Web of Science ®Google Scholar
• Pedersen BK, Hoffman-Goetz L. Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 2000; 80: 1055–81
   PubMed Web of Science ®Google Scholar
• Atamas SP, White B. Cytokine regulation of pulmonary fibrosis in scleroderma. Cytokine Growth Factor Rev 2003; 14: 537–50
   PubMed Web of Science ®Google Scholar
• Tikly M, Channa K, Theodorou P, Gulumian M. Lipid peroxidation and trace elements in systemic sclerosis. Clin Rheumatol 2006; 25: 320–4
   PubMed Web of Science ®Google Scholar
• Lau CS, O'Dowd A, Belch JJ. White blood cell activation in Raynaud's phenomenon of systemic sclerosis and vibration induced white finger syndrome. Ann Rheum Dis 1992; 51: 249–52
   PubMed Web of Science ®Google Scholar
• Volpe A, Biasi D, Caramaschi P, Mantovani W, Bambara LM, Canestrini S, et al. Levels of F2-isoprostanes in systemic sclerosis: correlation with clinical features. Rheumatology (Oxford) 2006; 45: 314–20
   PubMed Web of Science ®Google Scholar
• Musellim B, Ikitimur H, Uzun H, Ongen G. The oxidant–antioxidant balance in systemic sclerosis cases with interstitial lung involvement. Rheumatol Int 2006; 27: 163–7
   PubMed Web of Science ®Google Scholar
• Firuzi O, Fuksa L, Spadaro C, Bousova I, Riccieri V, Spadaro A, et al. Oxidative stress parameters in different systemic rheumatic diseases. J Pharm Pharmacol 2006; 58: 951–7
   PubMed Web of Science ®Google Scholar
• Ogawa F, Shimizu K, Muroi E, Hara T, Hasegawa M, Takehara K, et al. Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis. Rheumatology (Oxford) 2006; 45: 815–18
   PubMed Web of Science ®Google Scholar